A carregar...
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
We retrospectively reviewed outcomes of treatment with VIP (combination of etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma (STS). We analyzed the medical records of patients with advanced or relapsed STS who had undergone VIP treatment as second-line or...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5287961/ https://ncbi.nlm.nih.gov/pubmed/28121937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005942 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|